Bio-Rad Laboratories | BIO - Market Capitalization


Bio-Rad Laboratories reported $6.87B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Agilent USD 32.66B 5.2B Mar/2026
Becton, Dickinson and Co. USD 44.77B 10.52B Mar/2026
Bio Techne USD 8.18B 987M Mar/2026
Bruker USD 5.5B 1.66B Mar/2026
Charles River Laboratories USD 7.85B 2.17B Mar/2026
Danaher USD 128.46B 33.24B Mar/2026
General Electric Aerospace USD 296.49B 28.42B Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Mettler Toledo International USD 25.54B 2.94B Mar/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Repligen USD 6.64B 2.58B Mar/2026
Revvity USD 9.94B 1.03B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 160.86B 30.46B Mar/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Tosoh JPY 752.07B 12.52B Mar/2026
Waters USD 29.87B 7.25B Mar/2026